Mr. Mark Glibbery
January 5, 2006
Page 2 of 4
investment managers with sophisticated and specialized research from a variety of sources to
assist them in making investment decisions.2 The SEC has consistently reinforced this view
through its interpretations of Section 28(e).
Both Section 28(e) and the FSA’s current approach to client commission arrangements
permit the use of client commissions to pay for “execution” and “research” services. The
Institute recently expressed its strong support for SEC proposals to narrow and more clearly
define the types of services that constitute “execution” and “research” and may be obtained
through client commission arrangements.3 We have followed closely and support previous FSA
efforts along the same lines.
Unbundled Disclosure
We disagree with the FSA on its new requirement that investment managers—without
any corresponding legal duty on brokers—provide to their clients estimates of the monetary
value of the execution and proprietary research components of the brokerage commissions paid.
This approach has two shortcomings. First, the FSA approach requires investment managers to
assume liability for disclosing something that they cannot know, but can only estimate in good
faith. When fund commissions are used to acquire both execution and research services, only the
broker will know the commission it would charge for execution-only services.4 To comply with
the new rule, fund managers must either prevail upon brokers to provide the information,
estimate the allocation of bundled commission payments between execution and research on
their own, or perhaps do both when the information obtained from a broker does not seem
reliable to the manager.5
In addition, because investment managers will have to estimate execution and research
allocations, the FSA’s approach will generate inconsistent disclosure. Without any legal
obligation on brokers to provide an accurate and consistent breakdown of the research and
execution components of commissions, investment managers will use different methodologies to
allocate commission payments. Allocation methodologies could be based on the value of the
research to the manager, the presumed cost of the research to the broker, the hypothetical price
the broker would charge for the research, and/or comparable execution-only rates in other
2
Congress feared that “the future availability and quality of research and other services . . . could be jeopardized,
with potentially harmful consequences to all investors” if managers were required to select brokers based only on
the lowest available commission rate. See H.R. Rep. No. 123, 94th Cong., 1st Sess. 248 (1975).
3
See Letter from Paul Schott Stevens, President, Investment Company Institute, to Mr. Jonathan G. Katz, Secretary,
U.S. Securities and Exchange Commission, dated Nov. 25, 2005 (File No. S7-09-05) (hereinafter “2005 ICI
Letter”).
4
One of the FSA’s primary assumptions seems to be that an execution-only price exists in every market and country
with every broker. This is not the case, especially for many international markets where there are no execution-only
benchmarks. For the many markets and many brokers that do not offer execution-only services, there simply is no
available execution-only price.
5
It appears that some brokers are not responding to managers’ requests for information. See “Fund Managers
Weigh Options for Splitting Commission Costs,” Compliance Reporter (Nov. 14, 2005). In those cases, managers
will have to rely on their own estimates of the execution and research components of bundled commission
payments.
Mr. Mark Glibbery
January 5, 2006
Page 3 of 4
venues. Even a single manager using a consistent methodology may generate different (and
seemingly inconsistent) disclosure, because, for example, the “value” of the same research
received from a particular broker may be greater for one type of investment strategy than
another. The lack of comparability and reliability of the information disclosed significantly
diminishes its utility and may lead to client and market confusion rather than the desired
improvement in market efficiency and competition.
Our concern over the accuracy and reliability of unbundled disclosure reflects, in part, the
unique features of mutual fund regulation in the United States. Here, unbundled disclosure
would likely be required to be made in the fund prospectus, with corresponding liability risks.
The disclosure would also be presented to fund boards, which would then be required to consider
the disclosure as part of the annual decision to retain the investment adviser. In these contexts,
the reliability and comparability of the disclosure is absolutely crucial.
In questions 1 and 2 of the consultation paper, the FSA generally seeks input on whether
commission-related disclosure in the retail fund context should be made directly to retail
investors or to an “investors’ representative.” As made clear by the preceding discussion, we
agree with the FSA that unbundled disclosure to retail investors would detract from the key
messages in fund disclosure documents that help investors make investment decisions. While we
agree in principle that an investors’ representative is far more likely than retail investors to
understand and be able to act upon detailed commission-related disclosure, we believe it is
unlikely that unbundled commission disclosure provided even to an investors’ representative will
be meaningful unless brokers have a legal obligation to provide accurate figures to the
investment manager.6
* * * * *
We appreciate the opportunity to express our views on this complex and important topic.
We would also like to express our appreciation to the FSA representatives who met with Paul
Stevens and Bob Grohowski of the Institute in December 2005 to discuss the topics addressed in
this consultation.
If you have any questions about our comments or need any additional information, please
contact me at +1 202 326-5815 or Bob Grohowski at +1 202 371-5430.
Sincerely,
/s/ Elizabeth Krentzman
Elizabeth Krentzman
General Counsel
6
In this situation, investment managers would still be responsible for ensuring that the aggregate value of execution
and research services received from a broker is reasonable in light of the commission paid, as required by COB
7.18.3 in the United Kingdom (or Section 28(e) of the Securities Exchange Act in the United States). But the
investment manager would not have to assume sole liability for estimating and disclosing unbundled commission
rates that it cannot know without mandatory input from the broker.
Mr. Mark Glibbery
January 5, 2006
Page 4 of 4
About the Investment Company Institute
The Investment Company Institute seeks to encourage adherence to high ethical
standards, promote public understanding, and otherwise advance the interests of funds, their
shareholders, directors, and advisers. The Institute’s membership includes 8,537 open-end
investment companies (mutual funds), 669 closed-end investment companies, 157 exchange-
traded funds, and 5 sponsors of unit investment trusts. Mutual fund members of the Institute
have total assets of approximately $8.672 trillion (representing 98 percent of all assets of US
mutual funds); these funds serve approximately 89.5 million shareholders in more than 52.6
million households. Many of the Institute's investment adviser members render investment
advice to both investment companies and other clients. In addition, the Institute’s membership
includes 187 associate members, which render investment management services exclusively to
non-investment company clients. A substantial portion of the total assets managed by U.S.-
registered investment advisers is managed by these Institute members and associate members.
Latest Comment Letters:
TEST - ICI Comment Letter Opposing Sales Tax on Additional Services in Maryland
ICI Comment Letter Opposing Sales Tax on Additional Services in Maryland
ICI Response to the European Commission on the Savings and Investments Union